Drug-induced immune thrombocytopenic purpura secondary to sunitinib

Current Oncology

Volumn 15, Issue 3, 2008, Pages 40-42

  Trinkaus, M ^a   Trudeau, M ^a   Callum, Jeannie ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Sunitinib; Thromboyctopenia

Indexed keywords

IMMUNOGLOBULIN; OMEPRAZOLE; SUNITINIB; TRANEXAMIC ACID; TRASTUZUMAB;

ADULT; BREAST CANCER; CASE REPORT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPEPSIA; ECCHYMOSIS; EPISTAXIS; FALLING; FEMALE; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LOADING DRUG DOSE; METASTASIS; PETECHIA; PHYSICAL EXAMINATION; REVIEW; SKIN BRUISING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; VISCERAL METASTASIS;

EID: 54349087074     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v15i3.233     Document Type: Review

References (10)

1. Chow LQ, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol 2007;25:884-96.
2. Atkins M, Jones CA, Kirkpatrick P. Sunitinib maleate. Nat Rev Drug Discov 2006;5:279-80.
3. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.
4. Faivre S, Delbaldo C, Vera K, et al. Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 2006;24:25-35.
5. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-7.
6. Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura, Br J Haematol 2006;133:364-74.
7. Ustun C, Dainer, P, Hendricks L, Bruker CT, Burgess R. Association of breast cancer and immune thrombocytopenic purpura. South Med J 2002;95:1335-7.
8. Peffault de Latour R, Des Guetz G, Laurence V, et al. Breast cancer associatied with idiopathic thrombocytopenic purpura: a single center series of 10 cases. Am J Clin Oncol 2004;27:333-6.
9. Kapiteijn E, Brand A, Kroep J, Gelderblom H. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 2007;18:1745-7.
10. Feldman DR, Martorella AJ, Robbins RJ, Motzer RJ. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 2007;99:974-5.